Crossmark

Comparing ethanol lock therapy versus vancomycin lock in a salvation strategy for totally implantable vascular access device infections due to coagulase-negative staphylococci (the ETHALOCK study): a prospective double-blind randomized clinical trial

Crossref DOI link: https://doi.org/10.1007/s10096-023-04702-w

Published Online: 2023-11-23

Published Print: 2024-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lesens, Olivier https://orcid.org/0000-0003-4359-0306
Forestier, Emmanuel

Botelho-Nevers, Elisabeth

Pavese, Patricia

David, Gary

Nougarede, Bertrand

Corbin, Violaine

Pereira, Bruno

Aumeran, Claire

Sauvat, Léo
License Information

Text and Data Mining valid from 2023-11-23

Version of Record valid from 2023-11-23
More Information

Article History

Received: 20 April 2023

Accepted: 6 November 2023

First Online: 23 November 2023

Declarations

:

: The study was approved by the CPP Sud-Est VI ethics committee n°AU 1120, the CNIL (French Data Protection Authority) n°1223379, and the ANSM (National Drug Agency) and registered under the Identifier number NCT02411331.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below